Gilead Sciences completes $7.8 billion Arcellx acquisition
Go back to Gilead Sciences completes $7.8 billion Arcellx acquisition| (NASDAQ: ACLX) | Delayed: 115.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.07 | 52 Week High | $ | |||
| Open | $115.07 | 52 Week Low | $ | |||
| Day High | $115.07 | P/E | N/A | |||
| Day Low | $115.07 | EPS | $ | |||
| Volume | 4,479 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.18 -0.69 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.87 | 52 Week High | $108.63 | |||
| Open | $126.13 | 52 Week Low | $71.39 | |||
| Day High | $126.51 | P/E | 69.16 | |||
| Day Low | $124.29 | EPS | $1.81 | |||
| Volume | 2,111,572 | |||||
